Table 4.
Modification of clinical symptoms related OSA after treatment.
| Patient characteristics (N = 99) | At inclusion % (N) | After 3 months % (N) | After 6 months % (N) | P |
|---|---|---|---|---|
| Symptoms at night | ||||
| Snoring | 61.6 (62) | 44.4 (44) | 6.0 (6) | 0.005*; <0.00001**; <0.00001*** |
| Difficulty for falling asleep | 46.5 (47) | 18.1 (18) | 11.1 (11) | <0.001*; <0.001**; 0.079*** |
| Difficulty breathing during sleep | 48.5 (48) | 5.1 (5) | 0.0 (0) | <0.00001*; <0.00001**; <0.00001*** |
| Disturbed sleep | 76.8 (76) | 73.7 (73) | 56.6 (55) | 0.310*; <0.001**; <0.003*** |
| Frequent awake | 38.3 (38) | 9.1 (9) | 0.0 (0) | <0.00001*; <0.00001**; 0.001*** |
| Nocturnal sweating | 52.5 (52) | 18.1 (18) | 2.0 (2) | <0.00001*; <0.00001**; <0.0001*** |
| Enuresis | 11.1 (11) | 0.0 (0) | 0.0 (0) | <0.0001*; <0.0001**; N/A*** |
| Daytime symptoms | ||||
| Abnormal behavior | 30.3 (30) | 17.2 (17) | 9.4 (9) | 0.014*; <0.0001**; 0.046*** |
| Irritable | 47.4 (47) | 37.3 (37) | 26.3 (26) | 0.075*; <0.001**; 0.046*** |
| Agitated | 29.3 (29) | 8.1 (8) | 0.0 (0) | <0.0001*; <0.00001**; 0.001*** |
| Sleepiness | 26.3 (26) | 13.1 (13) | 4.1 (4) | 0.010*; <0.0001**; 0.011*** |
*After 3 months vs. at inclusion; **After 6 months vs. at inclusion; ***After 6 months vs. after 3 months. NA, not applicable.